Classification of the risk of transmission of vaccine-preventable diseases among children under 2 years of age in the municipality of São Paulo, Brazil
Authors:
- Mariana de Souza AraújoMAMariana de Souza Araújo
- José Elisomar Silva de SantanaJSJosé Elisomar Silva de Santana
- Melissa PalmieriMPMelissa Palmieri
- Luciana Ursini NunesLNLuciana Ursini Nunes
- Thaís Moreira OliveiraTOThaís Moreira Oliveira
- Maria Eduarda Viana OliveiraMOMaria Eduarda Viana Oliveira
- Guilherme Augusto VelosoGVGuilherme Augusto Veloso
- Thales Philipe Rodrigues da SilvaThales Philipe Rodrigues da Silva
- Fernanda Penido MatozinhosFMFernanda Penido Matozinhos
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Epidemiologia
- Vol. 29
Abstract
Objective: To analyze the classification of the risk of transmission of vaccine-preventable diseases among children under 2 years of age in a large Brazilian municipality in 2022 and 2023. Method: Ecological epidemiological study using secondary data on vaccination coverage (VC) for nine immunobiologicals recommended in the vaccination schedule for children under 2 years of age. Immunobiological dose data were obtained from the National Immunization Program Information System (Sistema de Informações do Programa Nacional de Imunizações - SI-PNI), while data were collected from the Ministry of Health website and filtered by place of residence. Data were analyzed using the R software package. Results: In 2022, 100% of the Health Surveillance Units (Unidades de Vigilância em Saúde - UVIS) showed low VC for the second dose of the measles-mumps-rubella (MMR) vaccine. In the same year, 61% and 54% of the UVIS achieved adequate VC for the hepatitis A and human rotavirus vaccines, respectively. In 2023, improvements in VC were observed for most vaccines, except for the meningococcal C and varicella vaccines, which showed a reduction in the number of UVIS achieving adequate VC. Regarding the classification of the risk of reintroduction of vaccine-preventable diseases, the proportion classified as “low and very low” increased from 0% in 2022 to 10.7% in 2023. Conclusion: VC improved in 2023 for most vaccines analyzed across the UVIS. However, variations in VC were observed according to vaccine type and year. These findings reinforce the need to maintain regional actions aimed at achieving vaccination targets, given the indications of a recovery in VC.Keywords
This publication has 13 references indexed in Scilit:
- Socioeconomic inequalities in vaccine uptake: A global umbrella reviewPLOS ONE, 2023
- Cobertura vacinal e o movimento antivacina: o impacto na saúde pública no BrasilRevista Baiana de Saúde Pública, 2023
- Hesitação da vacina da febre amarela e sua relação com influências contextuais, individuais ou de grupo e questões específicas da vacina: uma revisão de escopoCiencia & Saude Coletiva, 2023
- Hesitação vacinal em crianças menores de cinco anos: revisão de escopoRevista Brasileira de Enfermagem, 2023
- Pela reconquista das altas coberturas vacinaisCadernos de Saude Publica, 2023
- Cobertura vacinal em crianças menores de um ano no estado de Minas Gerais, BrasilCiencia & Saude Coletiva, 2022
- Hesitação e recusa vacinal em países com sistemas universais de saúde: uma revisão integrativa sobre seus efeitosSaúde em Debate, 2022
- “Pandemic fear” and COVID-19: mental health burden and strategiesBrazilian Journal of Psychiatry, 2020
- Vaccine hesitancy: Definition, scope and determinantsVaccine, 2015
- Hospital-based Surveillance to Evaluate the Impact of Rotavirus Vaccination in São Paulo, BrazilThe Pediatric Infectious Disease Journal, 2010